T46.0X2A Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, initial encounter

Name of the Condition

• Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, initial encounter

Summary

This condition describes intentional self-harm resulting from exposure to cardiac-stimulant glycosides or related drugs, requiring an initial medical encounter. Cardiac-stimulant glycosides (e.g., digoxin) are used to treat heart conditions like atrial fibrillation or heart failure. Intentional self-harm indicates deliberate ingestion or administration with the intent to cause harm. Clinical presentation varies based on dose and individual factors, with symptoms ranging from mild to severe.

Causes

Intentional self-harm poisoning occurs when a person deliberately takes an excessive amount of cardiac-stimulant glycosides or similar drugs. This may involve intentional overdose, misuse of prescribed medications, or access to these substances for self-harm purposes. The intent to cause harm distinguishes this scenario from accidental or therapeutic-related events.

Risk Factors

• History of mental health conditions (e.g., depression, anxiety) or suicidal ideation.
• Access to cardiac-stimulant glycosides (e.g., prescribed medications or stored supplies).
• Prior episodes of self-harm or substance misuse.
• Social or environmental stressors contributing to intentional harm.

Symptoms

• Nausea, vomiting, or abdominal pain.
• Irregular heart rhythms (arrhythmias), including bradycardia or tachycardia.
• Dizziness, fainting, or syncope.
• Visual disturbances (e.g., blurred vision, yellow-green halos around lights).
• Weakness, fatigue, or confusion.
• Seizures or cardiac arrest in severe cases.

Diagnosis

Diagnosis involves a patient history to confirm intentional self-harm and exposure to cardiac-stimulant glycosides. Clinical evaluation includes assessing symptoms, vital signs, and cardiac monitoring (e.g., ECG) for arrhythmias. Laboratory tests may measure drug levels, electrolytes, and renal function to guide management. Toxicology screening can confirm exposure, though results may be delayed.

Treatment Options

Treatment focuses on stabilizing the patient, reversing toxicity, and addressing underlying intent. Interventions may include activated charcoal (if ingestion is recent), antidotes (e.g., digoxin-specific Fab fragments), electrolyte correction (e.g., potassium or magnesium), and cardiac monitoring. Psychological evaluation and support are critical for addressing self-harm behavior.

Prognosis and Follow-Up

Prognosis depends on the dose, time to treatment, and presence of complications (e.g., arrhythmias, renal failure). Early intervention improves outcomes. Follow-up includes monitoring for recurrence, mental health support, and medication safety education. Long-term care may involve psychiatric care or substance use treatment.

Complications

• Severe arrhythmias (e.g., ventricular tachycardia, heart block).
• Cardiac arrest or sudden death.
• Renal failure due to toxicity.
• Neurological damage (e.g., seizures, coma).
• Electrolyte imbalances (e.g., hypokalemia).

Lifestyle & Prevention

• Secure storage of medications to prevent access.
• Education on proper dosing and disposal of unused drugs.
• Mental health support for individuals at risk of self-harm.
• Regular follow-up with healthcare providers to address underlying conditions.

When to Seek Professional Help

Seek immediate medical attention if self-harm with cardiac-stimulant glycosides is suspected or confirmed. Symptoms like severe nausea, dizziness, irregular heartbeat, or loss of consciousness require urgent care. Psychological evaluation is essential to address intent and prevent recurrence.

Tips for Medical Coders

Document the intent (intentional self-harm) and encounter type (initial) clearly. Include details on exposure, clinical presentation, and management. Ensure the code aligns with the patient’s history and clinical findings. Use additional codes (e.g., for mental health conditions) as appropriate, but avoid referencing other specific code numbers.